ROR1 and B-cell chronic lymphocytic leukemia: For example, chronic lymphocytic leukemia patients with high ROR1 expression had significantly shorter therapy-free survival and OS, suggesting that ROR1 is associated with more aggressive disease (Cui et al., 2016).